Filing Details

Accession Number:
0001209191-20-051169
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-18 17:00:09
Reporting Period:
2020-09-16
Accepted Time:
2020-09-18 17:00:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1492426 Horizon Therapeutics Public Ltd Co HZNP Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1716059 Irina Konstantinovsky C/O Horizon Therapeutics Plc
Connaught House, 1St Fl, 1 Burlington Rd
Dublin L2 4
Evp, Chief Human Resources Off No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2020-09-16 8,919 $78.88 36,022 No 4 S Direct
Ordinary Shares Acquisiton 2020-09-17 21,351 $14.05 57,373 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2020-09-17 21,351 $0.00 21,351 $14.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
50,461 2027-09-10 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020.
  2. 25% of the 131,606 shares originally subject to the stock option vested and became exercisable on September 11, 2018, and the remaining shares vest in equal monthly installments thereafter.